UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Wellington Shields & Co. LLC

Wellington Shields & Co. LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 47.3% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 238 shares of the healthcare conglomerate’s stock after selling 214 shares during the period. Wellington Shields & Co. LLC’s holdings in UnitedHealth Group were worth $121,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Macroview Investment Management LLC grew its position in UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the period. Delos Wealth Advisors LLC boosted its stake in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $31,000. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $31,000. Finally, Signature Resources Capital Management LLC boosted its stake in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on UNH shares. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Tuesday. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Argus raised their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Finally, TD Cowen raised their price target on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $614.17.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Down 1.5 %

Shares of NYSE UNH opened at $589.75 on Thursday. The company has a 50 day simple moving average of $564.99 and a 200-day simple moving average of $516.56. The company has a market capitalization of $542.80 billion, a P/E ratio of 36.05, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter last year, the firm earned $6.14 EPS. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.